Serum Prostatic Antigen Measurement in Localized Prostatic Cancer: Correlation with Clinical Course
- 1 December 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 128 (6), 1216-1218
- https://doi.org/10.1016/s0022-5347(17)53431-x
Abstract
Serial serum prostatic antigen measurements were performed on patients treated for localized prostatic carcinoma. There was good correlation of mean serum prostatic antigen levels and the surgical stage of the disease. Among patients treated by radical prostatectomy there was good correlation of an elevated serum prostatic antigen and the development of metastatic disease. Serum prostatic antigen apparently is a good indicator and predictor of the development of distant metastasis in this group of patients.This publication has 13 references indexed in Scilit:
- PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN1Journal of Urology, 2002
- The Role of Biologic Tumor Markers in Testicular CancerCancer, 1980
- Clinical significance of serum and bone marrow acid phosphataseThe Prostate, 1980
- Overview of chemotherapy programs of the NPCPThe Prostate, 1980
- An assessment of bone scans for monitoring osseous metastases in patients being treated for prostate carcinomaThe Prostate, 1980
- The role of radiography, computed tomography and bone scanning in prostatic cancerThe Prostate, 1980
- Clinical significance of serum acid phosphatase levels in advanced prostatic carcinomaUrology, 1976
- Prognostic Usefulness of Serum Acid Phosphatase Levels in carcinoma of the ProstateJournal of Urology, 1974
- Acid Phosphatase in UrologySurgical Clinics of North America, 1965
- Significance of Increased Phosphatase Activity of Bone at the Site of Osteoplastic Metastases Secondary to Carcinoma of the Prostate GlandThe American Journal of Cancer, 1936